Lexagene (CVE:LXG) Trading Up 2%

Lexagene Holdings Inc (CVE:LXG)’s stock price was up 2% during mid-day trading on Wednesday . The company traded as high as C$0.52 and last traded at C$0.52, approximately 188,500 shares traded hands during mid-day trading. An increase of 177% from the average daily volume of 68,122 shares. The stock had previously closed at C$0.51.

The company has a current ratio of 3.41, a quick ratio of 2.93 and a debt-to-equity ratio of 96.03. The stock has a 50 day simple moving average of C$0.59 and a 200-day simple moving average of C$0.65. The firm has a market cap of $34.70 million and a P/E ratio of -4.16.

About Lexagene (CVE:LXG)

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in the life sciences and diagnostics industries. The company's platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.

Read More: Why investors pay attention to retained earnings

Receive News & Ratings for Lexagene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexagene and related companies with MarketBeat.com's FREE daily email newsletter.